| Date Filed | Type | Description |
| 06/30/2023 |
4
| Meeker David P (Director) has filed a Form 4 on Trevi Therapeutics, Inc.|
Txns:
| Granted 30,000 options to buy
@ $2.27, valued at
$68.1k
|
|
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/01/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 06/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/11/2022 |
4
| Meeker David P (President and CEO) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.|
Txns:
| Granted 510,000 options to buy
@ $6.8, valued at
$3.5M
|
|
| 06/17/2021 |
4
| Meeker David P (Director) has filed a Form 4 on Trevi Therapeutics, Inc.|
Txns:
| Granted 20,000 options to buy
@ $2.25, valued at
$45k
|
|
| 03/31/2021 |
4
| Meeker David P (President and CEO) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.|
Txns:
| Bought 10,000 shares
@ $20.1713, valued at
$201.7k
|
|
| 02/16/2021 |
4
| Meeker David P (President and CEO) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.|
Txns:
| Granted 220,000 options to buy
@ $30.66, valued at
$6.7M
|
|
| 11/19/2020 |
4
| Meeker David P (Director) has filed a Form 4 on MyoKardia, Inc.|
Txns:
| Unknown transaction of 4,100 shares
@ $0
Disposed/sold 22,000 options to buy
@ $11.55, valued at
$254.1k
Disposed/sold 11,000 options to buy
@ $14, valued at
$154k
Disposed/sold 11,000 options to buy
@ $48.85, valued at
$537.4k
Disposed/sold 6,600 options to buy
@ $47.77, valued at
$315.3k
Disposed/sold 3,000 options to buy
@ $100.27, valued at
$300.8k
|
|
| 10/15/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 07/21/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/23/2020 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 06/22/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/18/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2020 |
4
| Meeker David P (Director) has filed a Form 4 on MyoKardia, Inc.|
Txns:
| Exercised 2,300 restricted stock units
@ $0 |
|
| 06/15/2020 |
4
| Meeker David P (Director) has filed a Form 4 on Trevi Therapeutics, Inc.|
Txns:
| Granted 14,210 options to buy
@ $4.1, valued at
$58.3k
|
|
| 06/21/2019 |
4
| Meeker David P (Director) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.|
Txns:
| Granted 15,000 options to buy
@ $22.93, valued at
$344k
|
|
| 06/17/2019 |
4
| Meeker David P (Director) has filed a Form 4 on MyoKardia Inc|
Txns:
| Granted 6,600 options to buy
@ $47.17, valued at
$311.3k
Granted 2,300 restricted stock units
@ $0 |
|
| 05/13/2019 |
4
| Meeker David P (10% Owner) has filed a Form 4 on Trevi Therapeutics, Inc.|
Txns:
| Converted 300,536 shares
@ $0
Converted 27,432 shares
@ $0
Converted 13,271 shares
@ $0
Bought 11,250 shares
@ $10, valued at
$112.5k
Converted 924,880 preferred shares
@ $0
Converted 192,000 preferred shares
@ $0
Converted 95,712 preferred shares
@ $0
Converted 869,565 preferred shares
@ $0
Converted 478,951 preferred shares
@ $0 |
|
| 05/08/2019 |
4
| Meeker David P (10% Owner) has filed a Form 4 on Trevi Therapeutics, Inc.|
Txns:
| Granted 23,684 options to buy
@ $10, valued at
$236.8k
|
|
| 05/07/2019 |
3
| Meeker David P (10% Owner) has filed a Form 3 on Trevi Therapeutics, Inc. |
| 06/14/2018 |
4
| Meeker David P (Director) has filed a Form 4 on MyoKardia Inc|
Txns:
| Granted 11,000 options to buy
@ $48.85, valued at
$537.4k
|
|
| 06/08/2018 |
4
| Meeker David P (Director) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.|
Txns:
| Granted 10,000 options to buy
@ $34.89, valued at
$348.9k
|
|
| 10/10/2017 |
4
| Meeker David P (Director) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.|
Txns:
| Converted 54,525 shares
@ $0
Bought 25,000 shares
@ $17, valued at
$425k
Converted 54,525 convertible preferred
@ $0 |
|
| 10/04/2017 |
3
| Meeker David P (Director) has filed a Form 3 on RHYTHM PHARMACEUTICALS, INC. |
| 06/16/2017 |
4
| Meeker David P (Director) has filed a Form 4 on MyoKardia Inc|
Txns:
| Granted 11,000 options to buy
@ $14, valued at
$154k
|
|
| 04/19/2017 |
4
| Meeker David P (Director) has filed a Form 4 on MyoKardia Inc |
| 04/19/2017 |
3
| Meeker David P (Director) has filed a Form 3 on MyoKardia Inc |
| 01/17/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/06/2011 |
4
| Meeker David P (ExecVP,COO) has filed a Form 4 on GENZYME CORP|
Txns:
| Unknown transaction of 10,551 shares
@ $74, valued at
$780.8k
Disposed/sold 29,250 shares
@ $74, valued at
$2.2M
Unknown transaction of 210 shares
@ $74, valued at
$15.5k
Unknown transaction of 375 shares
@ $74, valued at
$27.8k
Unknown transaction of 120 shares
@ $74, valued at
$8.9k
Unknown transaction of 621 shares
@ $74, valued at
$46k
Exercised 14,250 restricted stock units
@ $0
Exercised 15,000 restricted stock units
@ $0
Disposed/sold 60,000 options to buy
@ $51.52, valued at
$3.1M
Disposed/sold 15,000 options to buy
@ $30.57, valued at
$458.6k
Disposed/sold 20,000 options to buy
@ $50.02, valued at
$1M
|
|
| 09/22/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/18/2010 |
4
| Meeker David P (ExecVP,COO) has filed a Form 4 on GENZYME CORP|
Txns:
| Granted 60,000 options to buy
@ $51.52, valued at
$3.1M
|
|
| 05/26/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/25/2010 |
4
| Meeker David P (ExecVP,COO) has filed a Form 4 on GENZYME CORP|
Txns:
| Sold 16,488 shares
@ $49.06, valued at
$808.9k
Exercised 16,488 options to buy
@ $26.5, valued at
$436.9k
|
|
|